Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06693466 | NOT YET RECRUITING | Huntington Disease

Huntington's Disease and Pain
Sponsor:

Leiden University Medical Center

Information provided by (Responsible Party):

Susanne T de Bot, MD, PhD

Brief Summary:

The primary objective of this pilot study is to assess the feasibility of three internationally agreed pain test batteries in patients with Huntington Disease. The pain test batteries are developed to collect data about the facial expression of pain, body movements and vocalization of (non-) painful stimuli, and to collect data for testing the pain inhibition and facilitation. The study population will include 20 patients with genetically confirmed, adult-onset HD, in stage 1 (n=10) and stages 2 - 3 of HD (n = 10).

Condition or disease

Huntington Disease

Pain

Intervention/treatment

Facial expression block

Conditioned pain modulation block

Pain facilitation block

Detailed Description:

The primary objective of this pilot study is to assess the feasibility of a comprehensive experimental design with three internationally well-known experimental pain protocols in patients with Huntington Disease. The exploratory objectives are: * To explore the psychometric properties (inter-, intra-rater and test-retest reliability and measurement error) of the facial expression, body movements and vocalization items of an observational pain scale, the Pain Assessment in Impaired Cognition Scale (PAIC15), in patients with HD. * To measure the overall facial expression of pain in patients with HD. * To explore the prevalence and extent of endogenous pain modulation in HD (facilitation, inhibition and the balance between the two). * To make an initial estimate of the measurement error (i.e. agreement), stated as the systematic and random error of a patients' score that is not attributed to true changes in the construct to be measured, for each endpoint related in current study to pain processing in HD (e.g. facial expression and the endogenous pain modulation outcomes). Study design: An experimental, observational, cross-sectional study Study population: The study population will include 20 patients with genetically confirmed, adult-onset HD, in stage 1 (n=10) and stages 2 - 3 of HD (n = 10).

Study Type : OBSERVATIONAL
Estimated Enrollment : 20 participants
Official Title : Pain Processing and Pain Assessment in Huntington's Disease a Pilot Study
Actual Study Start Date : 2025-01
Estimated Primary Completion Date : 2025-12
Estimated Study Completion Date : 2026-07

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 21 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Genetically and clinically confirmed Adult-onset HD patients (≥ 21 years, CAG repeats ≥ 36; DCL of 4).
  • 2. Good general health apart from having HD. Note: Patients with chronic illness (e.g. hypertension) will be eligible if the illness is stable and well-controlled according to the investigator that will not impact the primary objectives of the study.
  • 3. Able to give written informed consent
Exclusion Criteria
  • 1. Juvenile and Pediatric Huntington's Disease (age at onset \<21 years).
  • 2. Patients in the late stage of the disease (UDHRS-TFC score \<3).
  • 3. Have medical, psychiatric, or other conditions (other than HD) that, according to the investigator, may compromise the patient's ability to understand the patient information sheet, to give informed consent, to comply with all study requirements, or to perform study assessments.
  • 4. Have a history of (in the past year) or current (ab)use of any drug, alcohol or medication that, in the opinion of the investigator, may seriously interfere with the primary objectives of the study.
  • 5. The presence of a sensorimotor neuropathy or any another disturbance significantly disturbing the somatosensory systems, based on medical history and/or clinical examination, that can interfere with the pain test battery.
  • 6. Women who are pregnant or breastfeeding
Huntington's Disease and Pain

Location Details

NCT06693466

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

Netherlands, South Holland

Leiden University Medical Center

Leiden, South Holland, Netherlands, 2333 FOR